Found: 7
Select item for more details and to access through your institution.
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Primary Melanoma: from History to Actual Debates.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 12, p. 1, doi. 10.1007/s11912-019-0843-x
- By:
- Publication type:
- Article
ASO Visual Abstract: Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 1, p. 573, doi. 10.1245/s10434-022-12600-2
- By:
- Publication type:
- Article
Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1176, doi. 10.3390/cancers12051176
- By:
- Publication type:
- Article
A systematic review and meta‐analysis of locoregional treatments for in‐transit melanoma.
- Published in:
- Journal of Surgical Oncology, 2019, v. 120, n. 6, p. 1056, doi. 10.1002/jso.25685
- By:
- Publication type:
- Article
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17739-8
- By:
- Publication type:
- Article